Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan in Pediatric Hypertension (1-5 Years)
NCT00171028Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2003
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valsartan in hypertension (HTN) (4 arms), sponsored by Novartis. Primary endpoint: Change from baseline systolic blood pressure at 4 weeks. Started Dec 2003; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00171028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171028.